CD8A and neoplasm: Moreover, it has been demonstrated that CD73+ tumor cells are resistant to PD-1 blockade and that the simultaneous blockade of CD73+ and PD-1+ could augment intra-tumoral CD8+ infiltration and enhance tumor control and survival in mice [32,33].